Evidence map›Paper›PMID 35540709›Full record

ReviewEuropean urology open science2022

What Is the Most Effective Management of the Primary Tumor in Men with Invasive Penile Cancer: A Systematic Review of the Available Treatment Options and Their Outcomes.

Vasileios I Sakalis, Riccardo Campi, Lenka Barreto, Herney Garcia Perdomo, Isabella Greco, Łukasz Zapala, Mithun Kailavasan, Tiago Antunes-Lopes, Jack David Marcus, Kenneth Manzie and 15 more

Open access · goldAbstract readReview
In one paragraph

Review in European urology open science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The evolution of penile reconstructive techniques in urology.International journal of impotence research · 2026
    Review
  4. Review
  5. Review
  6. Review
  7. Penile cancer treatment and sexuality: a narrative review.International journal of impotence research · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 20 institutions in 11 countries.

Vasileios I SakalisDepartment of Urology, Agios Pavlos General Hospital, Thessaloniki, Greece.
Riccardo CampiUnit of Oncologic Minimally-Invasive Urology and Andrology, Careggi University Hospital, San Luca Nuovo, Florence, Italy.
Lenka BarretoDepartment of Urology, University Hospital Nitra, Nitra, Slovakia.
Herney Garcia PerdomoDivision of Urology/Urooncology, Department of Surgery, School of Medicine, Universidad Del Valle, Cali, Colombia.
Isabella GrecoDepartment of Urological Minimally Invasive and Robotic Surgery and Kidney Transplantation, Careggi Hospital, University of Florence, Florence, Italy.
Łukasz ZapalaDepartment of Urology, Medical University of Warsaw, Warsaw, Poland.
Mithun KailavasanRoyal Derby Hospital, Derby, UK.
Tiago Antunes-LopesDepartment of Urology, Hospital de S. João, Porto, Portugal.
Jack David MarcusMulticancer Fighter Patient Advocate, Us TOO, New York, NY, USA.
Kenneth ManziePatient Advocate, ORCHID, UK.
John OsbornePatient Advocate, ORCHID, UK.
Benjamin AyresDepartment of Urology, St George's University Hospitals NHS Foundation Trust, London, UK.
Luc M F MoonenDepartment of Radiotherapy, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Andrea NecchiDepartment of Urology and Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Juanita CrookUniversity of British Columbia, British Columbia Cancer Agency, Kelowna, British Columbia, Canada.
Pedro OliveiraDepartment of Urology, The Christie NHS Foundation Trust, Manchester, UK.
Lance C PagliaroDepartment of Oncology, Mayo Clinic, Rochester, MN, USA.
Chris ProtzelHelios Clinics Schwerin, Schwerin, Germany.
Arie S ParnhamDepartment of Urology, The Christie NHS Foundation Trust, Manchester, UK.
Maarten AlbersenDepartment of Urology, University Hospitals Leuven, Leuven, Belgium.
Curtis A PettawayThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Philippe E SpiessDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Scott T TagawaDivision of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY, USA.
R Bryan RumbleAmerican Society of Clinical Oncology, Alexandria, VA, USA.
Oscar R BrouwerThe Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
The Netherlands Cancer Institute · NLAgios Pavlos General Hospital · GRAmerican Society of Clinical Oncology · USAzienda Ospedaliero-Universitaria Careggi · ITBC Cancer Agency · CACornell University · USFondazione IRCCS Istituto Nazionale dei Tumori · ITHelios Hospital Schwerin · DEHospital de São João · PTKU Leuven · BEMayo Clinic in Arizona · USMedical University of Warsaw · PLMoffitt Cancer Center · USPatient Advocate Foundation · USRoyal Derby Hospital · GBSt George’s University Hospitals NHS Foundation Trust · GBThe Christie NHS Foundation Trust · GBThe University of Texas MD Anderson Cancer Center · USUniversidad del Valle · COUniversity of Trás-os-Montes and Alto Douro · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: The primary lesion in penile cancer is managed by surgery or radiation. Surgical options include penile-sparing surgery, amputative surgery, laser excision, and Moh's micrographic surgery. Radiation is applied as external beam radiotherapy (EBRT) and brachytherapy. The treatment aims to completely remove the primary lesion and preserve a sufficient functional penile stump. Objective: To assess whether the 5-yr recurrence-free rate and other outcomes, such as sexual function, quality of life, urination, and penile preserving length, vary between various treatment options. Evidence acquisition: The EMBASE, MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials (CENTRAL; Cochrane HTA, DARE, HEED), Google Scholar, and ClinicalTrials.gov were searched for publications from 1990 through May 2021. Randomized controlled trials, nonrandomized comparative studies (NRCSs), and case series (CSs) were included. Evidence synthesis: The systematic review included 88 studies, involving 9578 men from 16 NRCSs and 72 CSs. The cumulative mean 5-yr recurrence-free rates were 82.0% for penile-sparing surgery, 83.9% for amputative surgery, 78.6% for brachytherapy, 55.2% for EBRT, 69.4% for lasers, and 88.2% for Moh's micrographic surgery, as reported from CSs, and 76.7% for penile-sparing surgery and 93.3% for amputative surgery, as reported from NRCSs. Penile surgery affects sexual function, but amputative surgery causes more appearance concerns. After brachytherapy, 25% of patients reported sexual dysfunction. Both penile-sparing surgery and amputative surgery affect all aspects of psychosocial well-being. Conclusions: Despite the poor quality of evidence, data suggest that penile-sparing surgery is not inferior to amputative surgery in terms of recurrence rates in selected patients. Based on the available information, however, broadly applicable recommendations cannot be made; appropriate patient selection accounts for the relative success of all the available methods. Patient summary: We reviewed the evidence of various techniques to treat penile tumor and assessed their effectiveness in oncologic control and their functional outcomes. Penile-sparing as well as amputative surgery is an effective treatment option, but amputative surgery has a negative impact on sexual function. Penile-sparing surgery and radiotherapy are associated with a higher risk of local recurrence, but preserve sexual function and quality of life better. Laser and Moh's micrographic surgery could be used for smaller lesions.

Indexed as

AmputationBrachytherapyExternal beam radiationLaserMoh’s micrographic surgeryPenile cancerPenile sparingPsychological well-beingQuality of lifeRecurrenceSexual functionSurgery

Identifiers

PMID35540709
PMCPMC9079254
OpenAlexW4225280466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.